Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/99446
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorZhou, D-
dc.creatorLiu, X-
dc.creatorLo, K-
dc.creatorHuang, Y-
dc.creatorFeng, Y-
dc.date.accessioned2023-07-10T03:01:28Z-
dc.date.available2023-07-10T03:01:28Z-
dc.identifier.urihttp://hdl.handle.net/10397/99446-
dc.language.isoenen_US
dc.publisherFrontiers Media S.A.en_US
dc.rights© 2022 Zhou, Liu, Lo, Huang and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_US
dc.rightsThe following publication Zhou D, Liu X, Lo K, Huang Y and Feng Y (2022) The effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general population. Front. Endocrinol. 13:1012383 is available at https://doi.org/10.3389/fendo.2022.1012383.en_US
dc.subjectTotal cholesterol/high-density lipoprotein cholesterol ratioen_US
dc.subjectAll-cause mortalityen_US
dc.subjectCardiovascular mortalityen_US
dc.subjectNonlinear associationen_US
dc.subjectPrognostic capacityen_US
dc.titleThe effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general populationen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume13-
dc.identifier.doi10.3389/fendo.2022.1012383-
dcterms.abstractBackground: The relationship between the total cholesterol/high-density lipoprotein cholesterol (TC/HDL-C) ratio and all−cause and cardiovascular mortality has not been elucidated. Herein, we intend to probe the effect of the TC/HDL-C ratio on all-cause and cardiovascular mortality in the general population.-
dcterms.abstractMethods: From the 1999–2014 National Health and Nutrition Examination Surveys (NHANES), a total of 32,405 health participants aged ≥18 years were included. The TC/HDL-C levels were divided into five groups: Q1: <2.86, Q2: 2.86–3.46, Q3: 3.46–4.12, Q4: 4.12–5.07, Q5: >5.07. Multivariate Cox regression models were used to explore the relationship between the TC/HDL-C ratio and cardiovascular and all-cause mortality. Two−piecewise linear regression models and restricted cubic spline regression were used to explore nonlinear and irregularly shaped relationships. Kaplan–Meier survival curve and subgroup analyses were conducted.-
dcterms.abstractResults: The population comprised 15,675 men and 16,730 women with a mean age of 43 years. During a median follow-up of 98 months (8.1 years), 2,859 mortality cases were recorded. The TC/HDL-C ratio and all-cause mortality showed a nonlinear association after adjusting for confounding variables in the restricted cubic spline analysis. Hazard ratios (HRs) of all-cause mortality were particularly positively related to the level of TC/HDL-C ratio in the higher range >5.07 and in the lower range <2.86 (HR 1.26; 95% CI 1.10, 1.45; HR 1.18; 95% CI 1.00, 1.38, respectively), although the HRs of cardiovascular disease mortality showed no difference among the five groups. In the two-piecewise linear regression model, a TC/HDL-C ratio range of ≥4.22 was positively correlated with cardiovascular mortality (HR 1.13; 95% CI 1.02, 1.25). In the subgroup analysis, a nonlinear association between TC/HDL-C and all-cause mortality was found in those aged <65 years, men, and the no lipid drug treatment population.-
dcterms.abstractConclusion: A nonlinear association between the TC/HDL-C ratio and all-cause mortality was found, indicating that a too-low or too-high TC/HDL-C ratio might increase all-cause mortality. However, for cardiovascular mortality, it does not seem so. The cutoff value was 4.22. The individuals had higher cardiovascular mortality with a TC/HDL-C ratio >4.22.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationFrontiers in Endocrinology, 2022, v. 13, 1012383-
dcterms.isPartOfFrontiers in Endocrinology-
dcterms.issued2022-
dc.identifier.scopus2-s2.0-85145287032-
dc.identifier.artn1012383-
dc.description.validate202307 bcch-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumbera2187aen_US
dc.identifier.SubFormID46933en_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextthe Key Area R&D Program of Guangdong Province (No.2019B020227005);the Climbing Plan of Guangdong Provincial People’s Hospital (DFJH2020022);Guangdong Provincial Clinical Research Center for Cardiovascular disease (2020B1111170011);Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention (No. Y0120220151)en_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Zhou_Effect_Total_Cholesterol.pdf940.33 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

84
Citations as of May 11, 2025

Downloads

34
Citations as of May 11, 2025

SCOPUSTM   
Citations

13
Citations as of Jun 5, 2025

WEB OF SCIENCETM
Citations

11
Citations as of Jun 5, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.